Abstract:Classical swine fever virus (CSFV) is the causative agent of classical swine fever (CSF), which is a highly contagious swine disease that causes significant economic loses to the pig industry worldwide. The envelope E2 glycoprotein of CSFV is the most important viral antigen in inducing protective immune response against CSF. In this study, we generated a mammalian cell clone (BCSFV-E2) that could stably produce a secreted form of CSFV E2 protein (mE2). The mE2 protein was shown to be N-linked glycosylated and formed a homodimer. The vaccine efficacy of mE2 was evaluated by immunizing pigs. Twenty-five 6-week-old Landrace piglets were randomly divided into five groups. Four groups were intramuscularly immunized with mE2 emulsified in different adjuvants twice at four-week intervals. One group was used as the control group. All mE2-vaccinated pigs developed CSFV-neutralizing antibodies two weeks after the first vaccination with neutralizing antibody titers ranging from 1:40 to 1:320. Two weeks after the booster vaccination, the neutralizing antibody titers increased greatly and ranged from 1:10,240 to 1:81,920. At 28 weeks after the booster vaccine was administered, the neutralizing antibody titers ranged from 1:80 to 1:10240. At 32 weeks after the first vaccination, pigs in all the groups were challenged with a virulent CSFV strain at a dose of 1 × 10(5) TCID50. At two weeks after the challenge, all the mE2-immunized pigs survived and exhibited no obvious symptoms of CSF. The neutralizing antibody titer at this time was 20,480. Unvaccinated pigs in the control group exhibited symptoms of CSF 3-4 days after challenge and were euthanized from 7-9 days after challenge when the pigs became moribund. These results indicate that the mE2 is a good candidate for the development of a safe and effective CSFV subunit vaccine.

Baculovirus Surface Display of GP5 Envelope Glycoprotein of PRRSV and E2 Envelope Glycoprotein of CSFV and Immunogenicity Analysis of the Displayed Proteins

Baculovirus Surface Display of GP3 Envelope Glycoprotein of PRRSV and Cap Protein of PCV-2 and Immunogenicity of the Displayed Proteins in Mouse Model

Baculovirus surface display of E0E1E2 envelope glycoprotein of CSFV and immunogenicity of the displayed proteins in mouse model

Baculovirus As a PRRSV and PCV2 Bivalent Vaccine Vector: Baculovirus Virions Displaying Simultaneously GP5 Glycoprotein of PRRSV and Capsid Protein of PCV2

Baculovirus Surface Display of E2 Envelope Glycoprotein of Classical Swine Fever Virus and Immunogenicity of the Displayed Proteins in A Mouse Model

Baculovirus Surface Display of E(rns) Envelope Glycoprotein of Classical Swine Fever Virus.

Construction and Immunogenicity of Pseudotype Baculovirus Expressing GP5 and M Protein of Porcine Reproductive and Respiratory Syndrome Virus

Expression of E2 Protein of Classical Swine Fever Virus Shimen Strain Using Baculovrius Expression System

Immunogenicity of Envelope Gp5 Protein Displayed on Baculovirus and Protective Efficacy Against Virulent Porcine Reproductive and Respiratory Syndrome Virus Challenge in Piglets

Immunogenicity of the Envelope GP3 Protein of Porcine Reproductive and Respiratory Syndrome Virus Displayed on Baculovirus.

Generation and Evaluation of Recombinant Baculovirus Coexpressing <i>GP5</i> and <i>M</i> Proteins of Porcine Reproductive and Respiratory Syndrome Virus Type 1

Surface Displaying of Swine IgG1 Fc Enhances Baculovirus-Vectored Vaccine Efficacy by Facilitating Viral Complement Escape and Mammalian Cell Transduction

Development of a Combined Genetic Engineering Vaccine for Porcine Circovirus Type 2 and Mycoplasma Hyopneumoniae by a Baculovirus Expression System

Generation and Evaluation of Recombinant Baculovirus Coexpressing GP5 and M Proteins of Porcine Reproductive and Respiratory Syndrome Virus Type 1

Baculovirus Surface Display of E Envelope Glycoprotein of Japanese Encephalitis Virus and Its Immunogenicity of the Displayed Proteins in Mouse and Swine Models.

Prokaryotic Expression of GP5 of PRRSV and Analysis of Its Immunoreactivity

Baculovirus Surface Display Cap Protein of PCV2

Construction of Recombinant Pseudorabies Virus Coexpressing E and M Protein of Porcine Reproductive and Respiratory Syndrome Virus Fused with VP22 Protein of Bovine Herpesvirus 1 and Its Immunogenicity in Mice

Construction of Recombinant Porcine Reproductive and Respiratory Syndrome Virus Expressing CSFV E2 Glycoprotein

Generation and Efficacy Evaluation of Recombinant Classical Swine Fever Virus E2 Glycoprotein Expressed in Stable Transgenic Mammalian Cell Line

[Eukaryotic expression of GP5 and M protein of porcine reproductive and respiratory syndrome virus and immunogenicity evaluation]